National Medical Care Company (TADAWUL:4005)
Saudi Arabia
· Delayed Price · Currency is SAR 144.50
+2.50 (1.76%)
At close: Dec 4, 2025
TADAWUL:4005 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,568 | 1,294 | 1,082 | 917.93 | 845.38 | 808.95 | Upgrade
|
| Revenue Growth (YoY) | 28.43% | 19.59% | 17.85% | 8.58% | 4.50% | 14.19% | Upgrade
|
| Cost of Revenue | 1,007 | 845.11 | 714.93 | 630.99 | 601.08 | 587.78 | Upgrade
|
| Gross Profit | 560.65 | 448.58 | 366.85 | 286.95 | 244.3 | 221.17 | Upgrade
|
| Selling, General & Admin | 209.67 | 167.64 | 124.53 | 93.08 | 79.09 | 107.06 | Upgrade
|
| Other Operating Expenses | -2.85 | -6.33 | -4.03 | -8.35 | -8.19 | - | Upgrade
|
| Operating Expenses | 241.85 | 194.03 | 120.13 | 89.68 | 79.9 | 107.06 | Upgrade
|
| Operating Income | 318.8 | 254.55 | 246.72 | 197.27 | 164.4 | 114.11 | Upgrade
|
| Interest Expense | -29.88 | -22.74 | -3.5 | - | - | - | Upgrade
|
| Interest & Investment Income | 19.55 | 19.48 | 21.37 | 1.24 | - | 0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 8.97 | Upgrade
|
| EBT Excluding Unusual Items | 308.46 | 251.29 | 264.59 | 198.5 | 164.4 | 123.3 | Upgrade
|
| Legal Settlements | 42.34 | 42.34 | - | - | - | - | Upgrade
|
| Pretax Income | 350.8 | 293.63 | 264.59 | 198.5 | 164.4 | 123.3 | Upgrade
|
| Income Tax Expense | 16.1 | -4.54 | 23.67 | 28.43 | 28.04 | 26.03 | Upgrade
|
| Net Income | 334.7 | 298.16 | 240.93 | 170.07 | 136.36 | 97.27 | Upgrade
|
| Net Income to Common | 334.7 | 298.16 | 240.93 | 170.07 | 136.36 | 97.27 | Upgrade
|
| Net Income Growth | 21.95% | 23.76% | 41.66% | 24.73% | 40.18% | 21.45% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Change (YoY) | -0.26% | -0.18% | - | - | - | - | Upgrade
|
| EPS (Basic) | 7.49 | 6.66 | 5.37 | 3.79 | 3.04 | 2.17 | Upgrade
|
| EPS (Diluted) | 7.49 | 6.66 | 5.37 | 3.79 | 3.04 | 2.17 | Upgrade
|
| EPS Growth | 22.27% | 23.98% | 41.66% | 24.73% | 40.18% | 21.45% | Upgrade
|
| Free Cash Flow | 368.95 | 136.63 | 412.73 | 185.83 | 61.61 | 93.18 | Upgrade
|
| Free Cash Flow Per Share | 8.26 | 3.05 | 9.20 | 4.14 | 1.37 | 2.08 | Upgrade
|
| Dividend Per Share | 2.000 | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | - | - | 100.00% | - | - | -50.00% | Upgrade
|
| Gross Margin | 35.75% | 34.67% | 33.91% | 31.26% | 28.90% | 27.34% | Upgrade
|
| Operating Margin | 20.33% | 19.68% | 22.81% | 21.49% | 19.45% | 14.11% | Upgrade
|
| Profit Margin | 21.34% | 23.05% | 22.27% | 18.53% | 16.13% | 12.02% | Upgrade
|
| Free Cash Flow Margin | 23.53% | 10.56% | 38.15% | 20.24% | 7.29% | 11.52% | Upgrade
|
| EBITDA | 397.48 | 315.14 | 290.94 | 239.17 | 214.56 | 170.31 | Upgrade
|
| EBITDA Margin | 25.35% | 24.36% | 26.90% | 26.05% | 25.38% | 21.05% | Upgrade
|
| D&A For EBITDA | 78.68 | 60.6 | 44.22 | 41.9 | 50.16 | 56.2 | Upgrade
|
| EBIT | 318.8 | 254.55 | 246.72 | 197.27 | 164.4 | 114.11 | Upgrade
|
| EBIT Margin | 20.33% | 19.68% | 22.81% | 21.49% | 19.45% | 14.11% | Upgrade
|
| Effective Tax Rate | 4.59% | - | 8.95% | 14.32% | 17.06% | 21.11% | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.